Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article December 9 2022
METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
Cancer Res (2022)
Research Article December 9 2022
ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation
Cancer Res (2022)
Research Article December 9 2022
Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer
Cancer Res CAN-22-2709.
Brief Report December 9 2022
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models
Cancer Res (2022)
Research Article December 8 2022
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer
Cancer Res CAN-22-2912.
Research Article December 8 2022
PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells
Cancer Res CAN-22-2370.
Research Article December 8 2022
Elevated methionine flux drives pyroptosis evasion in persister cancer cells
Cancer Res CAN-22-1002.
Brief Report December 5 2022
Estimation of neutral mutation rates and quantification of somatic variant selection using canceffectsizeR
Cancer Res CAN-22-1508.
Research Article December 5 2022
Pharmacological targeting of androgen receptor elicits context-specific effects in estrogen receptor-positive breast cancer
Cancer Res CAN-22-1016.
Research Article December 2 2022
Spatially-resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intra-tumoral heterogeneity
Cancer Res CAN-22-3050.
Brief Report December 2 2022
Meta-analysis of human cancer single cell RNA-seq datasets using the IMMUcan database
Cancer Res CAN-22-0074.
Research Article November 30 2022
Single-cell analysis in lung adenocarcinoma implicates RNA editing in cancer innate immunity and patient prognosis
Cancer Res CAN-22-1062.
Review Article November 30 2022
Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)
Cancer Res (2022)
Review Article November 30 2022
Cell Competition in Carcinogenesis
Cancer Res (2022)
Research Article November 30 2022
Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
Cancer Res (2022)
Research Article November 30 2022
A pro-regenerative environment triggers premalignant to malignant transformation of senescent hepatocytes.
Cancer Res CAN-22-1477.
Research Article November 22 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Cancer Res CAN-22-1533.
Research Article November 21 2022
The oncogenic FOXL2 C134W mutation is a key driver of granulosa cell tumors
Cancer Res CAN-22-1880.
Research Article November 21 2022
Loss of NF1 in melanoma confers sensitivity to SYK kinase inhibition
Cancer Res CAN-22-0883.
Research Article November 21 2022
Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma
Cancer Res CAN-22-0677.
Research Article November 21 2022
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states
Cancer Res CAN-22-0423.
Research Article November 18 2022
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
Cancer Res CAN-21-4309.
Research Article November 15 2022
Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort
Cancer Res CAN-22-1641.
Research Article November 10 2022
Genome-wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk
Cancer Res CAN-22-1888.
Research Article November 10 2022
MEX3A mediates p53 degradation to suppress ferroptosis and facilitate ovarian cancer tumorigenesis
Cancer Res CAN-22-1159.
Research Article November 10 2022
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Cancer Res (2022)
Research Article November 9 2022
Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer
Cancer Res CAN-22-1433.
Research Article November 9 2022
Genetic ancestry inference from cancer-derived molecular data across genomic and transcriptomic platforms
Cancer Res CAN-22-0682.
Research Article November 8 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-mutant Pancreatic Cancer
Cancer Res CAN-22-0391.
Brief Report November 1 2022
Gene fusion detection and characterization in long-read cancer transcriptome sequencing data with FusionSeeker
Cancer Res CAN-22-1628.
Research Article November 1 2022
Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma
Cancer Res CAN-22-1029.
Brief Report October 26 2022
Common germline risk variants impact somatic alterations and clinical features across cancers
Cancer Res CAN-22-1492.
Research Article October 25 2022
Spatial transcriptomic analysis of a diverse patient cohort reveals a conserved architecture in triple-negative breast cancer
Cancer Res CAN-22-2682.
Review Article October 24 2022
Sex hormones in breast cancer immunity
Cancer Res CAN-22-1829.
Research Article October 20 2022
Landscape of microRNA regulatory network architecture and functional rerouting in cancer
Cancer Res CAN-20-0371.
Research Article October 20 2022
Shared cancer dataset analysis identifies and predicts the quantitative effects of pan-cancer somatic driver variants
Cancer Res CAN-22-1038.
Research Article October 20 2022
N-myc mediated translation control is a therapeutic vulnerability in medulloblastoma
Cancer Res CAN-22-0945.
Research Article October 20 2022
The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1α signaling in esophageal cancer
Cancer Res CAN-22-1922.
Review Article October 20 2022
Reimagining Cancer: Moving from the Cellular to the Tissue Level
Cancer Res CAN-22-1601.
Research Article October 20 2022
Extracellular vesicle-mediated transfer of lncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma
Cancer Res CAN-21-3432.
Research Article October 12 2022
Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer
Cancer Res CAN-22-0787.
Research Article October 12 2022
PRC2-mediated epigenetic suppression of type I IFN-STAT2 signaling impairs antitumor immunity in luminal breast cancer
Cancer Res CAN-22-0736.
Research Article October 11 2022
Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation
Cancer Res CAN-22-1294.
Research Article October 11 2022
Single-cell analysis reveals a CD4+ T cell cluster that correlates with PD-1 blockade efficacy
Cancer Res CAN-22-0112.
Research Article October 11 2022
Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma
Cancer Res CAN-22-2108.
Research Article October 11 2022
SMAD4 loss induces c-MYC-mediated NLE1 upregulation to support protein biosynthesis, colorectal cancer growth and metastasis
Cancer Res CAN-22-1247.
Research Article October 10 2022
Mono- and diunsaturated fatty acids sensitize cervical cancer to radiation therapy
Cancer Res CAN-21-4369.
Research Article October 10 2022
The lncRNA LENOX interacts with RAP2C to regulate metabolism and promote resistance to MAPK inhibition in melanoma.
Cancer Res CAN-22-0959.
Review Article October 10 2022
Wnt signaling in the phenotype and function of tumor-associated macrophages
Cancer Res CAN-22-1403.
Research Article October 7 2022
Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer
Cancer Res CAN-22-0455.
Page 1 of 2
Close Modal

or Create an Account

Close Modal
Close Modal